New cancer drug begins first human testing for multiple advanced cancers

NCT ID NCT05783622

Recruiting now Disease control Sponsor: Janux Therapeutics Source: ClinicalTrials.gov ↗

Summary

This is the first human study of an experimental drug called JANX008 for people with advanced solid tumors that have spread and stopped responding to standard treatments. The main goal is to find a safe dose and understand how the body handles the drug. Researchers will also look for early signs that the drug might help shrink tumors in cancers like lung, head & neck, kidney, and breast cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

City of Hope Medical Center
RECRUITING

Duarte, California, 91010, United States
Henry Ford Health System
RECRUITING

Detroit, Michigan, 48202, United States
Laura and Isaac Perlmutter Cancer Center NYU Langone Health
RECRUITING

New York, New York, 10016, United States
Ohio State University Hospital
RECRUITING

Columbus, Ohio, 43210, United States
Rhode Island Hospital
RECRUITING

Providence, Rhode Island, 02903, United States
Sarah Cannon Research Institute
RECRUITING

Nashville, Tennessee, 37203, United States
The Christ Hospital Cancer Center
RECRUITING

Cincinnati, Ohio, 45219, United States
The University of Texas, MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
UPMC Hillman Cancer Center
RECRUITING

Pittsburgh, Pennsylvania, 15232, United States
University of California San Diego Moores Cancer Center
RECRUITING

San Diego, California, 92093, United States
University of California, Davis Comprehensive Cancer Center
RECRUITING

Sacramento, California, 95817, United States
University of Chicago Medical Center
RECRUITING

Chicago, Illinois, 60637, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States
University of North Carolina at Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27599, United States
University of Pennsylvania, Abramson Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
Washington University
RECRUITING

St Louis, Missouri, 63110, United States
Winship Cancer Institute, Emory University
RECRUITING

Atlanta, Georgia, 30308, United States

Conditions

Explore the condition pages connected to this study.

COLORECTAL CARCINOMA NON SMALL CELL LUNG CANCER PANCREATIC DUCTAL ADENOCARCINOMA RENAL CELL CARCINOMA SMALL CELL LUNG CANCER SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK TRIPLE NEGATIVE BREAST CANCER